Faculty profile

Yohan Bossé

ResearcherMolecular MedicineUniversité Laval

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses and email address may be missing. Find their university profile.

Yohan Bossé

Researcher

Molecular Medicine

Health Sciences

Université Laval

Quebec City, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
1 publication in the last five years, latest in 2025.
Principal investigator on 11 research grants (11 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Genomics Lung Cancer Bioinformatics Twas Gene Expression Genotyping Causal Genes Expression Quantitative Trait Loci

Latest papers

Genome-wide association study of early-stage non-small cell lung cancer prognosis: a pooled analysis in the International Lung Cancer Consortium.
Carcinogenesis · 2025
Protein-altering germline mutations implicate novel genes related to lung cancer development.
Nature communications · 2020
Deleterious variants in DCHS1 are prevalent in sporadic cases of mitral valve prolapse.
Molecular genetics & genomic medicine · 2018 · senior author

All 5 publications

Latest funding

Circulating Anti-TREK-1 Autoantibodies as Diagnostic and Prognostic Biomarkers in Short-Coupled Ventricular Fibrillation
CIHR · 2026 · Co-investigator
$868,275
The lung molecular and cellular transition to adenocarcinoma
CIHR · 2025 · Nominated PI
$1,189,576
Identification of specific proteomic and genomic biomarkers for calcific aortic valve stenosis and its progression
CIHR · 2024 · Co-investigator
$757,352

All 26 grants and awards

5 publications.

Genome-wide association study of early-stage non-small cell lung cancer prognosis: a pooled analysis in the International Lung Cancer Consortium.

Dong M, Thakral A, Byrne KS, Bosse Y, Zhou H, Zhang Y, Atkins J, Haycock P, Brown MC, Murison K, Timens W, Sin DD, Kothari J, Gabriel AAG, Zaridze D, Savic M, Lissowska J, Świątkowska B, Janout V, Holcatova I, Mukeria A, Fernandez-Tardon G, Davies MPA, Triplette M, Schabath MB, Andrew AS, Chen C, Taylor F, Field JK, Tardon A, Shete SS, Brennan P, Landi MT, McKay J, Amos CI, Lin X, Christiani DC, Hung RJ, Liu G, Xu W

Carcinogenesis2025

DOI: 10.1093/carcin/bgaf031 PMID: 40746155

Protein-altering germline mutations implicate novel genes related to lung cancer development.

Ji X, Mukherjee S, Landi MT, Bosse Y, Joubert P, Zhu D, Gorlov I, Xiao X, Han Y, Gorlova O, Hung RJ, Brhane Y, Carreras-Torres R, Christiani DC, Caporaso N, Johansson M, Liu G, Bojesen SE, Le Marchand L, Albanes D, Bickeböller H, Aldrich MC, Bush WS, Tardon A, Rennert G, Chen C, Byun J, Dragnev KH, Field JK, Kiemeney LF, Lazarus P, Zienolddiny S, Lam S, Schabath MB, Andrew AS, Bertazzi PA, Pesatori AC, Diao N, Su L, Song L, Zhang R, Leighl N, Johansen JS, Mellemgaard A, Saliba W, Haiman C, Wilkens L, Fernandez-Somoano A, Fernandez-Tardon G, Heijden EHFMV, Kim JH, Davies MPA, Marcus MW, Brunnström H, Manjer J, Melander O, Muller DC, Overvad K, Trichopoulou A, Tumino R, Goodman GE, Cox A, Taylor F, Woll P, Wichmann E, Muley T, Risch A, Rosenberger A, Grankvist K, Johansson M, Shepherd F, Tsao MS, Arnold SM, Haura EB, Bolca C, Holcatova I, Janout V, Kontic M, Lissowska J, Mukeria A, Ognjanovic S, Orlowski TM, Scelo G, Swiatkowska B, Zaridze D, Bakke P, Skaug V, Butler LM, Offit K, Srinivasan P, Bandlamudi C, Hellmann MD, Solit DB, Robson ME, Rudin CM, Stadler ZK, Taylor BS, Berger MF, Houlston R, McLaughlin J, Stevens V, Nickle DC, Obeidat M, Timens W, Artigas MS, Shete S, Brenner H, Chanock S, Brennan P, McKay JD, Amos CI

Nature communications2020

DOI: 10.1038/s41467-020-15905-6 PMID: 32393777

Deleterious variants in DCHS1 are prevalent in sporadic cases of mitral valve prolapse.

Clemenceau A, Bérubé JC, Bélanger P, Gaudreault N, Lamontagne M, Toubal O, Clavel MA, Capoulade R, Mathieu P, Pibarot P, Bosse Y

Molecular genetics & genomic medicine2018Senior author

DOI: 10.1002/mgg3.347 PMID: 29224215

Genetic association analyses highlight biological pathways underlying mitral valve prolapse.

Dina C, Bouatia-Naji N, Tucker N, Delling FN, Toomer K, Durst R, Perrocheau M, Fernandez-Friera L, Solis J, PROMESA investigators, Le Tourneau T, Chen MH, Probst V, Bosse Y, Pibarot P, Zelenika D, Lathrop M, Hercberg S, Roussel R, Benjamin EJ, Bonnet F, Lo SH, Dolmatova E, Simonet F, Lecointe S, Kyndt F, Redon R, Le Marec H, Froguel P, Ellinor PT, Vasan RS, Bruneval P, Markwald RR, Norris RA, Milan DJ, Slaugenhaupt SA, Levine RA, Schott JJ, Hagege AA, MVP-France, Jeunemaitre X, Leducq Transatlantic MITRAL Network

Nature genetics2015

DOI: 10.1038/ng.3383 PMID: 26301497

Inflammation is associated with the remodeling of calcific aortic valve disease.

Coté N, Mahmut A, Bosse Y, Couture C, Pagé S, Trahan S, Boulanger MC, Fournier D, Pibarot P, Mathieu P

Inflammation2013

DOI: 10.1007/s10753-012-9579-6 PMID: 23225202

Something wrong or missing on this profile? Suggest a correction

Yohan Bossé

Research

Latest papers

Latest funding

Genome-wide association study of early-stage non-small cell lung cancer prognosis: a pooled analysis in the International Lung Cancer Consortium.

Protein-altering germline mutations implicate novel genes related to lung cancer development.

Deleterious variants in DCHS1 are prevalent in sporadic cases of mitral valve prolapse.

Genetic association analyses highlight biological pathways underlying mitral valve prolapse.

Inflammation is associated with the remodeling of calcific aortic valve disease.

Circulating Anti-TREK-1 Autoantibodies as Diagnostic and Prognostic Biomarkers in Short-Coupled Ventricular Fibrillation

The lung molecular and cellular transition to adenocarcinoma

Identification of specific proteomic and genomic biomarkers for calcific aortic valve stenosis and its progression

The lung molecular and cellular transition to adenocarcinoma

Molecular and Genetic Epidemiology to Understand Mitral Valve Prolapse

Sex and sex-hormones determine pulmonary morphological and single-nucleus transcriptomic responses in an animal model of sleep apnea.

A transcriptome- and proteome-wide association study of non-alcoholic fatty liver disease

Elucidating the role of lipoprotein(a) in calcific aortic valve stenosis using novel proteomic and imaging approaches

Canada Research Chair - Tier 2

Deciphering the role of PTPN6/SHP-1 and its mutant PTPN6/SHP-1Ala455Thr in the development of pulmonary emphysema

Frequent collaborators

Geoffrey Liu

Mark Lathrop

Patrick Mathieu

Ming-Sound Tsao

Stephen Lam

Wei Xu

Ma'en Obeidat

Philippe Joubert

Kiera Murison